We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News   Sep 11, 2019 | By Molly Campbell, Science Writer, Technology Networks

 
First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment
 
 
 

RELATED ARTICLES

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

Scientists Produce a Potential Vitamin and Alzheimer’s Drug in Yeast

News

By engineering and optimizing baker's yeast, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) has for the first time exploited the potential of making ergothioneine in yeast in a bio-based fashion.

READ MORE

Anti-inflammatory Drug May Raise Diabetes Risk

News

A commonly prescribed anti-inflammatory drug may increase diabetes risk after just one week of treatment, according to new findings presented at The Society for Endocrinology Annual Conference.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE